These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18776532)

  • 1. Base-modified ribonucleosides as potential anti-hepatitis C virus agents.
    Ivanov AV; Smirnova OA; Golubeva NA; Ivanov MA; Tunitskaya VL; Shipitsyn AV; Alexandrova LA
    Nucleic Acids Symp Ser (Oxf); 2008; (52):619-20. PubMed ID: 18776532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antiviral evaluation of 2'-C-methyl analogues of 5-alkynyl- and 6-alkylfurano- and pyrrolo[2,3-d]pyrimidine ribonucleosides.
    Januszczyk P; Fogt J; Boryski J; Izawa K; Onishi T; Neyts J; De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):713-23. PubMed ID: 20183611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2'-O,4'-C-alkylene-bridged ribonucleosides and their evaluation as inhibitors of HCV NS5B polymerase.
    Chapron C; Glen R; La Colla M; Mayes BA; McCarville JF; Moore S; Moussa A; Sarkar R; Seifer M; Serra I; Stewart A
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2699-702. PubMed ID: 24815510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent highlights in the synthesis of anti-HCV ribonucleosides.
    Piperno A; Cordaro M; Scala A; Iannazzo D
    Curr Med Chem; 2014; 21(16):1843-60. PubMed ID: 24372207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.
    Oh CH; Kim E; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analogue of AICAR with dual inhibitory activity against WNV and HCV NTPase/helicase: synthesis and in vitro screening of 4-carbamoyl-5-(4,6-diamino-2,5-dihydro-1,3,5-triazin-2-yl)imidazole-1-beta-D-ribofuranoside.
    Ujjinamatada RK; Baier A; Borowski P; Hosmane RS
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2285-8. PubMed ID: 17289387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
    Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the hepatitis C virus RNA-dependent RNA polymerase activity by the non-structural (NS) 3 helicase and the NS4B membrane protein.
    Piccininni S; Varaklioti A; Nardelli M; Dave B; Raney KD; McCarthy JE
    J Biol Chem; 2002 Nov; 277(47):45670-9. PubMed ID: 12235135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biogenic polyamines spermine and spermidine activate RNA polymerase and inhibit RNA helicase of hepatitis C virus.
    Korovina AN; Tunitskaya VL; Khomutov MA; Simonian AR; Khomutov AR; Ivanov AV; Kochetkov SN
    Biochemistry (Mosc); 2012 Oct; 77(10):1172-80. PubMed ID: 23157297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside analog inhibitors of hepatitis C virus replication.
    Carroll SS; Olsen DB
    Infect Disord Drug Targets; 2006 Mar; 6(1):17-29. PubMed ID: 16787301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B RNA-dependent RNA polymerase.
    Ding Y; Girardet JL; Smith KL; Larson G; Prigaro B; Wu JZ; Yao N
    Bioorg Chem; 2006 Feb; 34(1):26-38. PubMed ID: 16360193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives.
    Beaulieu PL; Bös M; Bousquet Y; Fazal G; Gauthier J; Gillard J; Goulet S; LaPlante S; Poupart MA; Lefebvre S; McKercher G; Pellerin C; Austel V; Kukolj G
    Bioorg Med Chem Lett; 2004 Jan; 14(1):119-24. PubMed ID: 14684311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(3-Thienyl)-5,6-dihydroxypyrimidine-4-carboxylic acids as inhibitors of HCV NS5B RdRp.
    Pacini B; Avolio S; Ercolani C; Koch U; Migliaccio G; Narjes F; Pacini L; Tomei L; Harper S
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6245-9. PubMed ID: 19800789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide prodrugs of 2'-deoxy-2'-spirooxetane ribonucleosides as novel inhibitors of the HCV NS5B polymerase.
    Jonckers TH; Vandyck K; Vandekerckhove L; Hu L; Tahri A; Van Hoof S; Lin TI; Vijgen L; Berke JM; Lachau-Durand S; Stoops B; Leclercq L; Fanning G; Samuelsson B; Nilsson M; Rosenquist Å; Simmen K; Raboisson P
    J Med Chem; 2014 Mar; 57(5):1836-44. PubMed ID: 24345201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytostatic and antiviral 6-arylpurine ribonucleosides. Part 7: synthesis and evaluation of 6-substituted purine l-ribonucleosides.
    Hocek M; Silhár P; Shih IH; Mabery E; Mackman R
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5290-3. PubMed ID: 16905315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Wu JZ; Yao N; Walker M; Hong Z
    Mini Rev Med Chem; 2005 Dec; 5(12):1103-12. PubMed ID: 16375756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.
    Klumpp K; Kalayanov G; Ma H; Le Pogam S; Leveque V; Jiang WR; Inocencio N; De Witte A; Rajyaguru S; Tai E; Chanda S; Irwin MR; Sund C; Winqist A; Maltseva T; Eriksson S; Usova E; Smith M; Alker A; Najera I; Cammack N; Martin JA; Johansson NG; Smith DB
    J Biol Chem; 2008 Jan; 283(4):2167-75. PubMed ID: 18003608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 4H-pyrazolo[1,5-a]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymerase.
    Deng Y; Shipps GW; Wang T; Popovici-Muller J; Rosner KE; Siddiqui MA; Duca J; Cooper AB; Cable M
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5363-7. PubMed ID: 19682898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.
    Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase.
    Furuta A; Tsubuki M; Endoh M; Miyamoto T; Tanaka J; Salam KA; Akimitsu N; Tani H; Yamashita A; Moriishi K; Nakakoshi M; Sekiguchi Y; Tsuneda S; Noda N
    Int J Mol Sci; 2015 Aug; 16(8):18439-53. PubMed ID: 26262613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.